Does TOFACITINIB Cause Polyp? 88 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Polyp have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
88
Reports of Polyp with TOFACITINIB
0.1%
of all TOFACITINIB reports
0
Deaths
19
Hospitalizations
How Dangerous Is Polyp From TOFACITINIB?
Of the 88 reports, 19 (21.6%) required hospitalization.
Is Polyp Listed in the Official Label?
Yes, Polyp is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Polyp?
ADALIMUMAB (709)
ALBUTEROL (264)
OLMESARTAN MEDOXOMIL (223)
PREDNISONE (220)
OCTREOTIDE (175)
HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL (162)
BUDESONIDE\FORMOTEROL (145)
MEPOLIZUMAB (141)
BUDESONIDE (137)
METHOTREXATE (134)
Which TOFACITINIB Alternatives Have Lower Polyp Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN